136 related articles for article (PubMed ID: 1324268)
1. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients.
Francisci D; Baldelli F; Papili R; Stagni G; Pauluzzi S
Eur J Epidemiol; 1995 Apr; 11(2):123-6. PubMed ID: 7672063
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of hepatitis A, B, and D viruses and human T-lymphocyte tropic viruses in Japanese drug abusers.
Kiyosawa K; Oofusa H; Saitoh H; Sodeyama T; Tanaka E; Furuta S; Itoh S; Ogata H; Kobuchi H; Kameko M
J Med Virol; 1989 Nov; 29(3):160-3. PubMed ID: 2559157
[TBL] [Abstract][Full Text] [Related]
4. [Viral infections in intravenous drug addicts. Clinical and prognostic significance].
Glória H; Ramalho F; Marinho R; Pedro M; Velosa J; Moura MC
Acta Med Port; 1991; 4(5):263-7. PubMed ID: 1785366
[TBL] [Abstract][Full Text] [Related]
5. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts].
Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F
Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of blood-borne viral infections in Afghanistan.
Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
[TBL] [Abstract][Full Text] [Related]
7. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations.
Huo TI; Wu JC; Wu SI; Chang AL; Lin SK; Pan CH; Huang YH; Chang FY; Lee SD
J Med Virol; 2004 Jan; 72(1):41-5. PubMed ID: 14635009
[TBL] [Abstract][Full Text] [Related]
8. High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.
Makiala-Mandanda S; Le Gal F; Ngwaka-Matsung N; Ahuka-Mundeke S; Onanga R; Bivigou-Mboumba B; Pukuta-Simbu E; Gerber A; Abbate JL; Mwamba D; Berthet N; Leroy EM; Muyembe-Tamfum JJ; Becquart P
J Clin Microbiol; 2017 May; 55(5):1299-1312. PubMed ID: 28202798
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence of antibodies against hepatitis C virus (HCV) among drug addicts].
Laskus T; Radkowski M; Werezyńska T; Horban A; Lupa E; Cianciara J; Slusarczyk J
Pol Arch Med Wewn; 1992 Jan; 87(1):8-13. PubMed ID: 1322535
[TBL] [Abstract][Full Text] [Related]
11. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
[TBL] [Abstract][Full Text] [Related]
12. Introduction of hepatitis delta virus into Polish drug community.
Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J; Halama G; Horban A
Infection; 1992; 20(1):43-4. PubMed ID: 1563812
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis serology: use and interpretation].
Grob PJ
Ther Umsch; 1992 May; 49(5):287-301. PubMed ID: 1377839
[TBL] [Abstract][Full Text] [Related]
14. [Infections with hepatitis B, C and delta viruses in patients with AIDS].
Stazka J; Babiuch L; Mian M; Szymańska B; Kamińska E; Panfist E; Kowalska T; Poznańska-Linde H
Przegl Epidemiol; 1991; 45(4):343-6. PubMed ID: 1668702
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection among drug addicts in Italy.
Stroffolini T; D'Egidio PF; Aceti A; Filippini P; Puoti M; Leonardi C; Almasio PL;
J Med Virol; 2012 Oct; 84(10):1608-12. PubMed ID: 22930509
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.
Takahashi M; Nishizawa T; Gotanda Y; Tsuda F; Komatsu F; Kawabata T; Hasegawa K; Altankhuu M; Chimedregzen U; Narantuya L; Hoshino H; Hino K; Kagawa Y; Okamoto H
Clin Diagn Lab Immunol; 2004 Mar; 11(2):392-8. PubMed ID: 15013993
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of hepatitis B and D virus infection among intravenous drug addicts in Israel.
Dan M; Rock M; Lilos P; Shany SB
Int J Epidemiol; 1993 Feb; 22(1):140-3. PubMed ID: 8449634
[TBL] [Abstract][Full Text] [Related]
18. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
Lake-Bakaar G; Bhat K; Govindarajan S
J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
[TBL] [Abstract][Full Text] [Related]
19. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
[TBL] [Abstract][Full Text] [Related]
20. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
